Jing Li

Title: Innovations in Cancer Treatment by Inventor Jing Li

Introduction

Jing Li is a prominent inventor based in Arlington, VA (US), known for his significant contributions to the field of cancer treatment. With a focus on developing novel methods and compositions, he has made strides in addressing challenges associated with drug-resistant tumors. His work is particularly relevant in the context of platinum-based chemotherapeutic resistance.

Latest Patents

Jing Li holds 2 patents that showcase his innovative approaches to cancer treatment. His latest patents include:

1. **Compositions and methods for treatment of platinum-based chemotherapeutic resistant tumors** - This patent details methods for treating tumors that resist platinum-based chemotherapy. It involves administering effective amounts of ursolic acid derivatives, either alone or in combination with platinum-based chemotherapeutics. The methods also include screening subjects based on SENP1 tumor expression to determine suitability for treatment.

2. **Compositions and methods for treatment of anticancer-drug resistant cancers** - This patent focuses on methods and compositions for treating tumors resistant to various anticancer drugs, including platinum-based chemotherapeutics.

Career Highlights

Jing Li is affiliated with The George Washington University, where he continues to advance research in cancer therapies. His work is characterized by a commitment to finding effective solutions for patients facing drug-resistant cancers.

Collaborations

Jing Li collaborates with esteemed colleagues, including Wenge Zhu and Yiliang Li, to enhance the impact of his research and develop innovative treatment strategies.

Conclusion

Jing Li's contributions to cancer treatment through his patents and research at The George Washington University highlight his dedication to improving patient outcomes. His innovative methods for addressing drug resistance in tumors represent a significant advancement in the field of oncology.